The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of the MDM2 promoter polymorphisms SNP285 and SNP309 on endometrial cancer risk among caucasians.
S. Knappskog
No relevant relationships to disclose
J. Trovik
No relevant relationships to disclose
J. Marcickiewisz
No relevant relationships to disclose
S. Tingulstad
No relevant relationships to disclose
A. Staff
No relevant relationships to disclose
K. Hveem
No relevant relationships to disclose
L. Vatten
No relevant relationships to disclose
H. B. Salvesen
No relevant relationships to disclose
P. E. Lonning
No relevant relationships to disclose